World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
125
Citations
53422
World Ranking
3116
National Ranking
27

Hui Y. Lan publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Hui Y. Lan sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 464 publications — 51st percentile

51% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Hui Y. Lan D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Hui Y. Lan sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 125 D-Index — 85th percentile

85% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Internal medicine
  • Cancer

His primary areas of investigation include Internal medicine, Endocrinology, Fibrosis, Renal fibrosis and Cancer research. His Internal medicine research incorporates themes from Signal transduction and Cell biology. His biological study spans a wide range of topics, including Proinflammatory cytokine, Cytokine and MAPK/ERK pathway.

His Renal fibrosis research is multidisciplinary, relying on both Myofibroblast and Kidney metabolism. His work carried out in the field of Cancer research brings together such families of science as Downregulation and upregulation, microRNA, Metastasis, Genetic enhancement and Transforming growth factor beta. His study explores the link between Pathology and topics such as Glomerulonephritis that cross with problems in Immunology, Lupus nephritis, Macrophage and Proteinuria.

His most cited work include:

  • Elevated Uric Acid Increases Blood Pressure in the Rat by a Novel Crystal-Independent Mechanism (938 citations)
  • Uric Acid Stimulates Monocyte Chemoattractant Protein-1 Production in Vascular Smooth Muscle Cells Via Mitogen-Activated Protein Kinase and Cyclooxygenase-2 (583 citations)
  • Transforming growth factor-β regulates tubular epithelial-myofibroblast transdifferentiation in vitro (429 citations)

What are the main themes of his work throughout his whole career to date?

Hui Y. Lan mostly deals with Internal medicine, Endocrinology, Immunology, Fibrosis and Glomerulonephritis. Receptor is closely connected to Signal transduction in his research, which is encompassed under the umbrella topic of Internal medicine. His Endocrinology study frequently draws connections between related disciplines such as Cell biology.

His study in Fibrosis is interdisciplinary in nature, drawing from both Inflammation and CTGF. Hui Y. Lan combines subjects such as Pathology, Basement membrane and Osteopontin with his study of Glomerulonephritis. Hui Y. Lan studied Kidney and Kidney disease that intersect with Nephrology and Nephropathy.

He most often published in these fields:

  • Internal medicine (56.94%)
  • Endocrinology (53.12%)
  • Immunology (25.00%)

What were the highlights of his more recent work (between 2011-2020)?

  • Internal medicine (56.94%)
  • Renal fibrosis (22.92%)
  • Endocrinology (53.12%)

In recent papers he was focusing on the following fields of study:

His primary areas of study are Internal medicine, Renal fibrosis, Endocrinology, Fibrosis and Cancer research. The various areas that Hui Y. Lan examines in his Internal medicine study include Diabetes mellitus, Type 2 diabetes and Gastroenterology. His Renal fibrosis research is multidisciplinary, incorporating perspectives in Transforming growth factor, Transforming growth factor beta, SMAD and microRNA.

His Endocrinology research is multidisciplinary, incorporating elements of Receptor and C-reactive protein. His studies deal with areas such as Inflammation, Downregulation and upregulation, Signal transduction and Kidney disease as well as Fibrosis. His Kidney disease research is multidisciplinary, incorporating perspectives in Immunology and Pharmacology.

Between 2011 and 2020, his most popular works were:

  • Inflammatory processes in renal fibrosis. (305 citations)
  • Role of the TGF-β/BMP-7/Smad pathways in renal diseases (221 citations)
  • miR-29 Inhibits Bleomycin-induced Pulmonary Fibrosis in Mice (202 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Internal medicine
  • Cancer

Hui Y. Lan spends much of his time researching Fibrosis, Renal fibrosis, Cancer research, Kidney and Transforming growth factor beta. His work deals with themes such as Downregulation and upregulation, Immunology and Kidney disease, which intersect with Fibrosis. His study in Renal fibrosis is interdisciplinary in nature, drawing from both Inflammation and Transforming growth factor.

Hui Y. Lan has researched Cancer research in several fields, including Endocrinology, Urokinase receptor, Internal medicine, CTGF and SMAD. The study incorporates disciplines such as Growth factor receptor and Cell growth in addition to Endocrinology. In his research on the topic of Internal medicine, Protein kinase B is strongly related with Diabetes mellitus.

Best Publications

  • TGF-β: the master regulator of fibrosis

    Xiao Ming Meng;David J. Nikolic-Paterson;Hui Yao Lan

  • Elevated Uric Acid Increases Blood Pressure in the Rat by a Novel Crystal-Independent Mechanism

    Marilda Mazzali;Jeremy Hughes;Yoon Goo Kim;J. Ashley Jefferson

  • Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism

    Marilda Mazzali;John Kanellis;Lin Han;Lili Feng

  • Uric Acid Stimulates Monocyte Chemoattractant Protein-1 Production in Vascular Smooth Muscle Cells Via Mitogen-Activated Protein Kinase and Cyclooxygenase-2

    John Kanellis;Susumu Watanabe;Jinhua Li;Duk Hee Kang

  • Uric Acid, Hominoid Evolution, and the Pathogenesis of Salt-Sensitivity

    Susumu Watanabe;Duk Hee Kang;Lili Feng;Takahiko Nakagawa

  • Transforming growth factor-β regulates tubular epithelial-myofibroblast transdifferentiation in vitro

    Jun-Ming Fan;Yee-Yung Ng;Prudence A. Hill;David J. Nikolic-Paterson

  • Diverse roles of TGF-β/Smads in renal fibrosis and inflammation.

    Hui Yao Lan

  • Macrophages: versatile players in renal inflammation and fibrosis

    Patrick Ming Kuen Tang;David J. Nikolic-Paterson;Hui Yao Lan

  • Renal tubule injury: a driving force toward chronic kidney disease.

    Bi-Cheng Liu;Tao-Tao Tang;Lin-Li Lv;Hui-Yao Lan

  • TGF-β/Smad signaling in renal fibrosis

    Xiao-Ming Meng;Patrick Ming-Kuen Tang;Jun Li;Hui Yao Lan

  • Inflammatory processes in renal fibrosis.

    Xiao-Ming Meng;David J Nikolic-Paterson;Hui Yao Lan

  • TGF-β/Smad3 Signaling Promotes Renal Fibrosis by Inhibiting miR-29

    Wei Qin;Arthur C.K. Chung;Xiao R. Huang;Xiao-Ming Meng

  • A Subpopulation of CD26+ Cancer Stem Cells with Metastatic Capacity in Human Colorectal Cancer

    Roberta Pang;Wai Lun Law;Andrew C.Y. Chu;Jensen T. Poon

  • Tubular epithelial-myofibroblast transdifferentiation in progressive tubulointerstitial fibrosis in 5/6 nephrectomized rats

    Yee-Yung Ng;Tung-Po Huang;Tung-Po Huang;Wu-Chang Yang;Wu-Chang Yang;Zheng-Ping Chen;Zheng-Ping Chen

  • Transforming growth factor-beta and Smad signalling in kidney diseases.

    Wansheng Wang;Vijay Koka;Hui Y Lan

  • Smad3-Mediated Upregulation of miR-21 Promotes Renal Fibrosis

    Xiang Zhong;Arthur Chi Kong Chung;Hai-Yong Chen;Xiaoming Meng

  • Inhibition of Renal Fibrosis by Gene Transfer of Inducible Smad7 Using Ultrasound-Microbubble System in Rat UUO Model

    Hui Y Lan;Wei Mu;Naruya Tomita;Xiao R Huang

  • Smad7 inhibits fibrotic effect of TGF-Beta on renal tubular epithelial cells by blocking Smad2 activation.

    Jinhua Li;Hong-Jian Zhu;Xiao R Huang;Kar N Lai

  • miR-192 Mediates TGF-β/Smad3-Driven Renal Fibrosis

    Arthur C.K. Chung;Xiao R. Huang;Xiaoming Meng;Hui Y. Lan

  • Role of the TGF-β/BMP-7/Smad pathways in renal diseases

    Xiao-Ming Meng;Arthur C. K. Chung;Hui Y. Lan

Frequent Co-Authors

David J. Nikolic-Paterson
David J. Nikolic-Paterson Monash Medical Centre
Robert C. Atkins
Robert C. Atkins Monash Medical Centre
Richard Bucala
Richard Bucala Yale University
Richard J. Johnson
Richard J. Johnson University of Colorado Denver
Christine N. Metz
Christine N. Metz Feinstein Institute for Medical Research
Benjamin C.Y. Wong
Benjamin C.Y. Wong University of Hong Kong
Joseph Leung
Joseph Leung University of California, Davis
Liang Qiao
Liang Qiao University of Sydney
Luan D. Truong
Luan D. Truong Cornell University
Alexander J. Szalai
Alexander J. Szalai University of Alabama at Birmingham

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA opens up a variety of alternative and closely related career paths. Several online degrees now offer flexible entry into healthcare roles, catering to diverse needs and budgets.

For those interested in administrative aspects, earning a certification in medical billing and coding can be both affordable and fast, with options to compare medical billing and coding certification cost across different accredited programs.

Aspiring nurses may consider options such as cheapest online nursing program for the most budget-friendly entry into this rewarding field. Those looking to advance their careers can explore accredited online nurse practitioner programs, which offer specialized training and higher earning potential.

Additionally, for nurses aiming to reach the highest levels in education and leadership, there are flexible and affordable online nursing doctoral programs available.

These online pathways make it possible to access respected credentials and step into healthcare careers or specializations without relocating or incurring excessive debt.

Best Scientists Citing Hui Y. Lan

Trending Scientists

Recently Published Articles